ARENA, Sabrina
ARENA, Sabrina
ONCOLOGIA
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
2019-01-01 Arena, Sabrina; Corti, Giorgio; Durinikova, Erika; Montone, Monica; Reilly, Nicole M; Russo, Mariangela; Lorenzato, Annalisa; Arcella, Pamela; Lazzari, Luca; Rospo, Giuseppe; Pagani, Massimiliano; Cancelliere, Carlotta; Negrino, Carola; Isella, Claudio; Bartolini, Alice; Cassingena, Andrea; Amatu, Alessio; Mauri, Gianluca; Sartore-Bianchi, Andrea; Mittica, Gloria; Medico, Enzo; Marsoni, Silvia; Linnebacher, Michael; Abrignani, Sergio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
2016-01-01 Van Emburgh, Beth O; Arena, Sabrina; Siravegna, Giulia; Lazzari, Luca; Crisafulli, Giovanni; Corti, Giorgio; Mussolin, Benedetta; Baldi, Federica; Buscarino, Michela; Bartolini, Alice; Valtorta, Emanuele; Vidal, Joana; Bellosillo, Beatriz; Germano, Giovanni; Pietrantonio, Filippo; Ponzetti, Agostino; Albanell, Joan; Siena, Salvatore; Sartore-Bianchi, Andrea; Di Nicolantonio, Federica; Montagut, Clara; Bardelli, Alberto
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes.
2012-01-01 Wallin JJ;Guan J;Edgar KA;Zhou W;Francis R;Torres AC;Haverty PM;Eastham-Anderson J;Arena S;Bardelli A;Griffin S;Goodall JE;Grimshaw KM;Hoeflich KP;Torrance C;Belvin M;Friedman LS
Adaptive mutability of colorectal cancers in response to targeted therapies
2019-01-01 Russo M.; Crisafulli G.; Sogari A.; Reilly N.M.; Arena S.; Lamba S.; Bartolini A.; Amodio V.; Magri A.; Novara L.; Sarotto I.; Nagel Z.D.; Piett C.G.; Amatu A.; Sartore-Bianchi A.; Siena S.; Bertotti A.; Trusolino L.; Corigliano M.; Gherardi M.; Lagomarsino M.C.; Di Nicolantonio F.; Bardelli A.
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.
2010-01-01 De Roock, W;* Jonker, Dj;* Di Nicolantonio, F; * Sartore-Bianchi, A; Tu, D; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, Cj; Khambata-Ford, S; Zalcberg, Jr; Simes, J; Karapetis, Cs; Bardelli, A; Tejpar, S. (*co-first authorship)
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
2014-01-01 S. Misale;S. Arena;S. Lamba;G. Siravegna;A. Lallo;S. Hobor;M. Russo;M. Buscarino;L. Lazzari;A. Sartore-Bianchi;K. Bencardino;A. Amatu;C. Lauricella;E. Valtorta;S. Siena;F. Di Nicolantonio;A. Bardelli
BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer
2008-01-01 Di Nicolantonio F; Martini M; Molinari F; Bianchi AS; Arena S; Saletti P; Mazzucchelli L; Frattini M; Siena S; Bardelli A
BRAF V600E is a determinant of sensitivity to proteasome inhibitors.
2013-01-01 Zecchin D;Boscaro V;Medico E;Barault L;Martini M;Arena S;Cancelliere C;Bartolini A;Crowley EH;Bardelli A;Gallicchio M;Di Nicolantonio F
Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer
2018-01-01 Arena, S.; Salati, M.; Sorgentoni, G.; Barbisan, F.; Orciani, M.*
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
2017-01-01 Ali, Moiez; Kaltenbrun, Erin; Anderson, Grace R.; Stephens, Sarah Jo; Arena, Sabrina; Bardelli, Alberto; Counter, Christopher M.; Wood, Kris C.*
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT)
2023-01-01 Marta Falcinelli , Giulia Dell’Omo, Elena Grassi , Elisa Mariella, Simonetta Maria Leto, Sharon Scardellato, Annalisa Lorenzato, Sabrina Arena , Andrea Bertotti, Livio Trusolino , Alberto Bardelli, Fabrizio d’Adda di Fagagna
Costruzione di linee cellulari isogeniche per mutazioni associate al cancro e loro applicazione per approcci di farmacogenomica
2008-01-01 Bardelli A; Di Nicolantonio F; Arena S
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.
2010-01-01 Di Nicolantonio F; Arena S; Tabernero J; Grosso S; Molinari F; Macarulla T; Russo M; Cancelliere C; Zecchin D; Mazzucchelli L; Sasazuki T; Shirasawa S; Geuna M; Frattini M; Baselga J; Gallicchio M; Biffo S; Bardelli A
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
2022-01-01 Amatu A.; Mauri G.; Tosi F.; Bencardino K.; Bonazzina E.; Gori V.; Ruggieri L.; Arena S.; Bardelli A.; Marsoni S.; Siena S.; Sartore-Bianchi A.
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer
2020-01-01 Amodio, Vito; Yaeger, Rona; Arcella, Pamela; Cancelliere, Carlotta; Lamba, Simona; Lorenzato, Annalisa; Arena, Sabrina; Montone, Monica; Mussolin, Benedetta; Bian, Yu; Whaley, Adele; Pinnelli, Marika; Murciano-Goroff, Yonina R; Vakiani, Efsevia; Valeri, Nicola; Liao, Wei-Li; Bhalkikar, Anuja; Thyparambil, Sheeno; Zhao, Hui-Yong; de Stanchina, Elisa; Marsoni, Silvia; Siena, Salvatore; Bertotti, Andrea; Trusolino, Livio; Li, Bob T; Rosen, Neal; Di Nicolantonio, Federica; Bardelli, Alberto; Misale, Sandra
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer
2015-01-01 S. Arena; B. Bellosillo; G. Siravegna; A. Martinez; I. Canadas; L. Lazzari; N. Ferruz; M. Russo; S. Misale; I. Gonzalez; M. Iglesias; E. Gavilan; G. Corti; S. Hobor; G. Crisafulli; M. Salido; J. Sanchez; A. Dalmases; J. Bellmunt; G.D. Fabritiis; A. Rovira; F. Di Nicolantonio; J. Albanell; A. Bardelli; C. Montagut
Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids
2021-01-01 Mauri, Gianluca; Durinikova, Erika; Amatu, Alessio; Tosi, Federica; Cassingena, Andrea; Rizzetto, Francesco; Buzo, Kristi; Arcella, Pamela; Aquilano, Maria Costanza; Bonoldi, Emanuela; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto; Sartore-Bianchi, Andrea; Arena, Sabrina
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES
2009-01-01 Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A.
Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells
2007-01-01 SALETTA F; MATULLO G; MANUGUERRA M; ARENA S; BARDELLI A; VINEIS P
Expression and Functional Regulation of Myoglobin in Epithelial Cancers
2009-01-01 Flonta SE; Arena S; Pisacane A; Michieli P; Bardelli A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin | 2019 | Arena, Sabrina; Corti, Giorgio; Durinikova, Erika; Montone, Monica; Reilly, Nicole M; Russo, Mariangela; Lorenzato, Annalisa; Arcella, Pamela; Lazzari, Luca; Rospo, Giuseppe; Pagani, Massimiliano; Cancelliere, Carlotta; Negrino, Carola; Isella, Claudio; Bartolini, Alice; Cassingena, Andrea; Amatu, Alessio; Mauri, Gianluca; Sartore-Bianchi, Andrea; Mittica, Gloria; Medico, Enzo; Marsoni, Silvia; Linnebacher, Michael; Abrignani, Sergio; Siena, Salvatore; Di Nicolantonio, Federica; Bardelli, Alberto | |
| Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer | 2016 | Van Emburgh, Beth O; Arena, Sabrina; Siravegna, Giulia; Lazzari, Luca; Crisafulli, Giovanni; Corti, Giorgio; Mussolin, Benedetta; Baldi, Federica; Buscarino, Michela; Bartolini, Alice; Valtorta, Emanuele; Vidal, Joana; Bellosillo, Beatriz; Germano, Giovanni; Pietrantonio, Filippo; Ponzetti, Agostino; Albanell, Joan; Siena, Salvatore; Sartore-Bianchi, Andrea; Di Nicolantonio, Federica; Montagut, Clara; Bardelli, Alberto | |
| Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes. | 2012 | Wallin JJ;Guan J;Edgar KA;Zhou W;Francis R;Torres AC;Haverty PM;Eastham-Anderson J;Arena S;Bardelli A;Griffin S;Goodall JE;Grimshaw KM;Hoeflich KP;Torrance C;Belvin M;Friedman LS | |
| Adaptive mutability of colorectal cancers in response to targeted therapies | 2019 | Russo M.; Crisafulli G.; Sogari A.; Reilly N.M.; Arena S.; Lamba S.; Bartolini A.; Amodio V.; Magri A.; Novara L.; Sarotto I.; Nagel Z.D.; Piett C.G.; Amatu A.; Sartore-Bianchi A.; Siena S.; Bertotti A.; Trusolino L.; Corigliano M.; Gherardi M.; Lagomarsino M.C.; Di Nicolantonio F.; Bardelli A. | |
| Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. | 2010 | De Roock, W;* Jonker, Dj;* Di Nicolantonio, F; * Sartore-Bianchi, A; Tu, D; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, Cj; Khambata-Ford, S; Zalcberg, Jr; Simes, J; Karapetis, Cs; Bardelli, A; Tejpar, S. (*co-first authorship) | |
| Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer | 2014 | S. Misale;S. Arena;S. Lamba;G. Siravegna;A. Lallo;S. Hobor;M. Russo;M. Buscarino;L. Lazzari;A. Sartore-Bianchi;K. Bencardino;A. Amatu;C. Lauricella;E. Valtorta;S. Siena;F. Di Nicolantonio;A. Bardelli | |
| BRAF V600E confers resistance to cetuximab or panitumumab metastatic colorectal cancer | 2008 | Di Nicolantonio F; Martini M; Molinari F; Bianchi AS; Arena S; Saletti P; Mazzucchelli L; Frattini M; Siena S; Bardelli A | |
| BRAF V600E is a determinant of sensitivity to proteasome inhibitors. | 2013 | Zecchin D;Boscaro V;Medico E;Barault L;Martini M;Arena S;Cancelliere C;Bartolini A;Crowley EH;Bardelli A;Gallicchio M;Di Nicolantonio F | |
| Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer | 2018 | Arena, S.; Salati, M.; Sorgentoni, G.; Barbisan, F.; Orciani, M.* | |
| Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance | 2017 | Ali, Moiez; Kaltenbrun, Erin; Anderson, Grace R.; Stephens, Sarah Jo; Arena, Sabrina; Bardelli, Alberto; Counter, Christopher M.; Wood, Kris C.* | |
| Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT) | 2023 | Marta Falcinelli , Giulia Dell’Omo, Elena Grassi , Elisa Mariella, Simonetta Maria Leto, Sharon Scardellato, Annalisa Lorenzato, Sabrina Arena , Andrea Bertotti, Livio Trusolino , Alberto Bardelli, Fabrizio d’Adda di Fagagna | |
| Costruzione di linee cellulari isogeniche per mutazioni associate al cancro e loro applicazione per approcci di farmacogenomica | 2008 | Bardelli A; Di Nicolantonio F; Arena S | |
| Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. | 2010 | Di Nicolantonio F; Arena S; Tabernero J; Grosso S; Molinari F; Macarulla T; Russo M; Cancelliere C; Zecchin D; Mazzucchelli L; Sasazuki T; Shirasawa S; Geuna M; Frattini M; Baselga J; Gallicchio M; Biffo S; Bardelli A | |
| Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study | 2022 | Amatu A.; Mauri G.; Tosi F.; Bencardino K.; Bonazzina E.; Gori V.; Ruggieri L.; Arena S.; Bardelli A.; Marsoni S.; Siena S.; Sartore-Bianchi A. | |
| EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer | 2020 | Amodio, Vito; Yaeger, Rona; Arcella, Pamela; Cancelliere, Carlotta; Lamba, Simona; Lorenzato, Annalisa; Arena, Sabrina; Montone, Monica; Mussolin, Benedetta; Bian, Yu; Whaley, Adele; Pinnelli, Marika; Murciano-Goroff, Yonina R; Vakiani, Efsevia; Valeri, Nicola; Liao, Wei-Li; Bhalkikar, Anuja; Thyparambil, Sheeno; Zhao, Hui-Yong; de Stanchina, Elisa; Marsoni, Silvia; Siena, Salvatore; Bertotti, Andrea; Trusolino, Livio; Li, Bob T; Rosen, Neal; Di Nicolantonio, Federica; Bardelli, Alberto; Misale, Sandra | |
| Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer | 2015 | S. Arena; B. Bellosillo; G. Siravegna; A. Martinez; I. Canadas; L. Lazzari; N. Ferruz; M. Russo; S. Misale; I. Gonzalez; M. Iglesias; E. Gavilan; G. Corti; S. Hobor; G. Crisafulli; M. Salido; J. Sanchez; A. Dalmases; J. Bellmunt; G.D. Fabritiis; A. Rovira; F. Di Nicolantonio; J. Albanell; A. Bardelli; C. Montagut | |
| Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids | 2021 | Mauri, Gianluca; Durinikova, Erika; Amatu, Alessio; Tosi, Federica; Cassingena, Andrea; Rizzetto, Francesco; Buzo, Kristi; Arcella, Pamela; Aquilano, Maria Costanza; Bonoldi, Emanuela; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto; Sartore-Bianchi, Andrea; Arena, Sabrina | |
| EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES | 2009 | Gallicchio M; Di Nicolantonio F; Arena S.; Zecchin D; Martini M; Flonta S; Stella G; Lamba S; Cancelliere C; Russo M; Geuna M; Appendino G; Fantozzi R; Medico E; Bardelli A. | |
| Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells | 2007 | SALETTA F; MATULLO G; MANUGUERRA M; ARENA S; BARDELLI A; VINEIS P | |
| Expression and Functional Regulation of Myoglobin in Epithelial Cancers | 2009 | Flonta SE; Arena S; Pisacane A; Michieli P; Bardelli A |